Form 4: Corcept Therapeutics Director G. Leonard Baker Jr. Reports Share Transfers

Director G. Leonard Baker Jr. of Corcept Therapeutics reported a transfer of shares through a gift of limited partnership interests and holdings through a limited partnership and trust.

Summary

• G. Leonard Baker Jr., a director at Corcept Therapeutics, filed a Form 4 detailing changes in his beneficial ownership of company stock.
• The report indicates a gift of limited partnership interests, resulting in a change in the number of shares he is deemed to beneficially own.
• Baker's holdings include shares held directly, through a limited partnership, and through a trust, with disclaimers of beneficial ownership except for his pecuniary interest.
• The transactions occurred on January 1, 2025.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not contain any information that would significantly impact investor sentiment. It is a neutral event.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is specific to the director's personal holdings and does not reflect the overall performance of the company.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• The reporting of indirect ownership through limited partnerships and trusts is common among corporate insiders.
• The disclaimers of beneficial ownership, except for pecuniary interest, are also standard practice in such filings.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the transactions of a company director.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Beneficial Ownership, Corcept Therapeutics, Director, Share Transfer, Limited Partnership, Trust, G. Leonard Baker Jr.